DHL Group has expanded its Life Sciences & Healthcare (LSH) campus in Florstadt near Frankfurt, Germany, into a European pharmaceutical hub as part of its global multibillion investment in DHL Health Logistics.
The German logistics giant recently announced plans to invest €2 billion over the next five years to boost its life sciences and healthcare logistics business across the Americas, Asia Pacific and Europe/Middle East/Africa, aiming to double revenues from this attractive growth market to over €10 billion by 2030. The acquisition of US-based courier Cryopdp will further boost the business, which is being consolidated under the new DHL Health Logistics brand.
Strategic focus
